Barclays’s Globus Medical GMED Stock Holding History

Barclays’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-25,000	Closed	-$1.26M	–	7219
2018 Q2	$1.26M	Buy	+25,000	New	+$1.3M	﹤0.01%	3026

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's GMED Position: Q1 2026 in Review

Barclays reduced its Globus Medical (GMED) stake by 24% in Q1 2026, selling an estimated $1.72M and leaving 60,386 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Barclays first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $68.7M in Q1 2023. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Barclays held 60,386 shares of Globus Medical worth $5.2M as of Q1 2026.
Barclays sold 19,206 Globus Medical shares in Q1 2026, an estimated $1.72M.
Globus Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1795 holding.
Barclays first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
Barclays's Globus Medical position peaked at $68.7M in Q1 2023.
603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.